199 related articles for article (PubMed ID: 36014884)
1. Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer.
Jiménez-Alonso JJ; Guillén-Mancina E; Calderón-Montaño JM; Jiménez-González V; Díaz-Ortega P; Burgos-Morón E; López-Lázaro M
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014884
[TBL] [Abstract][Full Text] [Related]
2. Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma.
Jiménez-Alonso JJ; Guillén-Mancina E; Calderón-Montaño JM; Jiménez-González V; Díaz-Ortega P; Burgos-Morón E; López-Lázaro M
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902018
[TBL] [Abstract][Full Text] [Related]
3. Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer.
Guillén-Mancina E; Jiménez-Alonso JJ; Calderón-Montaño JM; Jiménez-González V; Díaz-Ortega P; Burgos-Morón E; López-Lázaro M
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900331
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma.
Calderón-Montaño JM; Guillén-Mancina E; Jiménez-Alonso JJ; Jiménez-González V; Burgos-Morón E; Mate A; Pérez-Guerrero MC; López-Lázaro M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555771
[TBL] [Abstract][Full Text] [Related]
5. Dietary Manipulation of Amino Acids for Cancer Therapy.
Jiménez-Alonso JJ; López-Lázaro M
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447206
[TBL] [Abstract][Full Text] [Related]
6. Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.
Ninomiya I; Terada I; Yoshizumi T; Takino T; Nagai N; Morita A; Fushida S; Nishimura G; Fujimura T; Ohta T; Miwa K
Int J Cancer; 2004 Oct; 112(1):135-42. PubMed ID: 15305385
[TBL] [Abstract][Full Text] [Related]
7. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
[TBL] [Abstract][Full Text] [Related]
8. Effect of dietary proteins and amino acids on the susceptibility of mice to bacterial infections.
DUBOS RJ; SCHAEDLER RW
J Exp Med; 1958 Jul; 108(1):69-81. PubMed ID: 13549642
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
Jin K; Lan H; Xie B; He K; Xu Z; Li G; Han N; Teng L; Cao F
Cancer Biol Ther; 2012 Jul; 13(9):737-44. PubMed ID: 22617773
[TBL] [Abstract][Full Text] [Related]
10. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity-related anticancer therapy response differences in metastatic colon carcinoma: new hints to tumor-site-based personalized cancer therapy.
Pan W; Huang S; Zhang J; Zhao B; Wang H; Liu F; Jin K; Mou X
Hepatogastroenterology; 2013; 60(128):1927-34. PubMed ID: 24719929
[TBL] [Abstract][Full Text] [Related]
12. Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan.
Minami K; Morita M; Emi Y; Okamoto M; Tanaka E; Nagata S; Touyama T; Ohgaki K; Tanaka T; Okumura H; Suenaga T; Tokunaga S; Oki E; Kakeji Y; Akagi Y; Baba H; Natsugoe S; Maehara Y;
Int J Clin Oncol; 2017 Jun; 22(3):505-510. PubMed ID: 28101757
[TBL] [Abstract][Full Text] [Related]
13. An amino acid-defined diet impairs tumour growth in mice by promoting endoplasmic reticulum stress and mTOR inhibition.
Ragni M; Ruocco C; Tedesco L; Carruba MO; Valerio A; Nisoli E
Mol Metab; 2022 Jun; 60():101478. PubMed ID: 35367410
[TBL] [Abstract][Full Text] [Related]
14. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer.
Figueiredo Junior AG; Forones NM
Arq Gastroenterol; 2014; 51(3):186-91. PubMed ID: 25296077
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Int J Colorectal Dis; 2019 Apr; 34(4):629-639. PubMed ID: 30661101
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
[TBL] [Abstract][Full Text] [Related]
17. Dietary fish oil suppresses human colon tumour growth in athymic mice.
Calder PC; Davis J; Yaqoob P; Pala H; Thies F; Newsholme EA
Clin Sci (Lond); 1998 Mar; 94(3):303-11. PubMed ID: 9616265
[TBL] [Abstract][Full Text] [Related]
18. A metastatic colon cancer model using nonoperative transanal rectal injection.
Donigan M; Loh BD; Norcross LS; Li S; Williamson PR; DeJesus S; Ferrara A; Gallagher JT; Baker CH
Surg Endosc; 2010 Mar; 24(3):642-7. PubMed ID: 19688392
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer.
Shi H; Jiang J; Ji J; Shi M; Cai Q; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Lett; 2014 Jul; 349(2):128-35. PubMed ID: 24746899
[TBL] [Abstract][Full Text] [Related]
20. Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
Suto T; Ishiguro M; Hamada C; Kunieda K; Masuko H; Kondo K; Ishida H; Nishimura G; Sasaki K; Morita T; Hazama S; Maeda K; Mishima H; Ike H; Sadahiro S; Sugihara K; Okajima M; Saji S; Sakamoto J; Tomita N
Int J Clin Oncol; 2017 Jun; 22(3):494-504. PubMed ID: 28078540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
